Bioavailability of nerodilol-based transdermal therapeutic system of nicorandil in human volunteers

Journal of Controlled Release

Volumn 106, Issue 1-2, 2005, Pages 111-122

  Krishnaiah, Y S R ^a   Al Saidan, S M ^a   Chandrasekhar, D V ^b   Satyanarayana, V ^c  

^a KUWAIT UNIVERSITY   (Kuwait)

^b ANDHRA UNIVERSITY   (India)

^c Sipra Labs Pvt Ltd   (India)

Author keywords

Bioavailability; Human volunteers; Nerodilol; Nicorandil; Preparation; TTS

Indexed keywords

BIOASSAY; BIOLOGICAL MEMBRANES; CONCENTRATION (PROCESS); DRUG DOSAGE; PLASMAS; SKIN;

BIOAVAILABILITY; HUMAN VOLUNTEERS; NERODILOL; NICORANDIL; PREPARATION; TRANSDERMAL THERAPEUTIC SYSTEM (TTS);

DRUG PRODUCTS;

ADHESIVE AGENT; ETHYLENE VINYL ACETATE COPOLYMER; EVA 2825; HYDROXYPROPYLMETHYLCELLULOSE; NERODILOL; NICORANDIL; SESQUITERPENE DERIVATIVE; TACKWHITE A 4MED; UNCLASSIFIED DRUG;

ADULT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG PENETRATION; DRUG RELEASE; DRUG TRANSPORT; HEATING; HUMAN; HUMAN EXPERIMENT; IMMEDIATE DRUG RELEASE; MALE; MEMBRANE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RAT; SKIN IRRITATION; SKIN PERMEABILITY; STEADY STATE; TABLET FORMULATION;

ADMINISTRATION, CUTANEOUS; ADULT; ANIMALS; ANTI-ARRHYTHMIA AGENTS; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; DRUG CARRIERS; GELS; HUMANS; MALE; METHYLCELLULOSE; NICORANDIL; POLYMERS; RATS; SESQUITERPENES; SKIN ABSORPTION; VASODILATOR AGENTS; VINYL COMPOUNDS;

EID: 23744515339     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2005.04.021     Document Type: Article

References (36)

1. M.R. Prausnitz, S. Mitragotri, and R. Langer Current status and future potential of transdermal drug delivery Nat. Rev. Drug Discov. 3 2004 115 124
2. J.A. Bouwstra, G.S. Gooris, J.A. van der Spek, and W. Bras Structural investigations of human stratum corneum by small-angle X-ray scattering J. Invest. Dermatol. 97 1991 1005 1012
3. P.M. Elias The stratum corneum revisited J. Dermatol. 23 1996 756 758
4. A.C. Williams, and B.W. Barry Penetration enhancers Adv. Drug Deliv. Rev. 56 2004 603 618
5. B.B. Michniak, M.R. Player, J.M. Chapman, and J.W. Sowell Azone analogues as penetration enhancers: effect of different vehicles on hydrocortisone acetate skin permeation and retention J. Control. Release 32 1994 147 154
6. S. Sato, Y. Hirotani, N. Ogura, E. Sasaki, and S. Kitagawa Enhancing effect of N-dodecyl-2-pyrrolidone on the percutaneous absorption of 5-fluorouracil derivatives Chem. Pharm. Bull. 46 1998 831 836
7. H. Tanojo, J.A. Bouwstra, H.E. Junginger, and H.E. Bodde In vitro human skin barrier modulation by fatty acids: skin permeation and thermal analysis studies Pharm. Res. 14 1997 42 49
8. Y. Morimoto, Y. Wada, T. Seki, and K. Sugibayashi In vitro skin permeation of morphine hydrochloride during the finite application of penetration-enhancing system containing water, ethanol and l-menthol Biol. Pharm. Bull. 25 2002 134 136
9. T. Akimoto, K. Kawahara, Y. Nagasem, and T. Aoyagi Polymeric transdermal drug penetration enhancer: enhancing effect of oligodimethylsiloxane containing a glucopyranosyl end group J. Control. Release 77 2001 49 57
10. M. Endo, T. Yamamoto, and T. Ijuin Effect of nonionic surfactants on the percutaneous absorption tenoxicam Chem. Pharm. Bull. 44 1996 865 867
11. M.A. Yamane, A.C. Williams, and B.W. Barry Terpene penetration enhancers in propylene glycol/water co-solvent systems: effectiveness and mechanism of action J. Pharm. Pharmacol. 47 1995 978 989
12. K. Zhao, S. Singh, and J. Singh Effect of menthone on the in vitro percutaneous absorption of tamoxifen and skin reversibility Int. J. Pharm. 219 2001 177 181
13. H.K. Vaddi, P.C. Ho, and S.Y. Chan Terpenes in propylene glycol as skin-penetration enhancers: permeation and partition of haloperidol, Fourier transform infrared spectroscopy, and differential scanning calorimetry J. Pharm. Sci. 91 2002 1639 1651
14. S. Gao, and J. Singh In vitro percutaneous absorption enhancement of lipophilic drug tamoxifen by terpenes J. Control. Release 51 1998 193 199
15. K. Zhao, and J. Singh In vitro percutaneous absorption enhancement of propranolol hydrochloride through porcine epidermis by terpenes/ethanol J. Control. Release 62 1999 359 366
16. K. Zhao, and J. Singh Mechanisms of percutaneous absorption of tamoxifen by terpenes: eugenol, d-nerodilol and menthone J. Control. Release 55 1998 253 260
17. A.F. El-Kattan, C.S. Asbill, N. Kim, and B.B. Michniak The effects of terpene enhancers on the percutaneous permeation of drugs with different lipophilicities Int. J. Pharm. 215 2001 229 240
18. J. Frampton, M.M. Buckley, and A. Fitton Nicorandil, a review of its pharmacology and therapeutic efficacy in angina pectoris Drugs 44 1992 625 655
19. D.M. Kerins, R.M. Robertson, and D. Robertson Drugs used for the treatment of myocardial ischemia J.G. Hardman L.E. Limbird Goodman and Gilman's The Pharmacological Basis of Therapeutics 10th ed. 2001 McGraw Hill Medical Publishing Division New York 864
20. A. Frydman Pharmacokinetic profile of nicorandil in humans: an overview J. Cardiovasc. Pharmacol. 20 Suppl 3 1992 S34 S44
21. K. Sato, K. Sugibayashi, and Y. Morimoto Species differences in percutaneous absorption of nicorandil J. Pharm. Sci. 80 1991 104 107
22. K. Sato, K. Sugibayashi, Y. Morimoto, H. Omiya, and N. Enomoto Prediction of the in-vitro human skin permeability of nicorandil from animal data J. Pharm. Pharmacol. 41 1989 379 383
23. D.N. Tipre, and P.R. Vavia Formulation optimization and stability study of transdermal therapeutic system of nicorandil Pharm. Dev. Technol. 7 2002 325 332
24. S.M. Al-Saidan, Y.S.R. Krishnaiah, D.V. Chandrasekhar, J.K. Lalla, B. Rama, B. Jayaram, and P. Bhaskar Formulation of an HPMC gel drug reservoir system with ethanol-water as a solvent system and nerodilol as a penetration enhancer for enhancing in vitro transdermal delivery of nicorandil Skin Pharmacol. Appl. Skin Physiol. 17 2004 310 320
25. Y.S.R. Krishnaiah, S.M. Al-Saidan, D.V. Chandrasekhar, and J.K. Lalla Effect of nerodilol and carvone on the in vitro transdermal delivery of nicorandil AAPS J. 6 4 2004 (Abstract W4263)
26. P.R. Keshary, and Y.W. Chien Mechanism of transdermal controlled nitroglycerin administration: Part 2. Assessment of rate controlling steps Drug Dev. Ind. Pharm. 10 1984 1663 1699
27. W.L. Hayton, and T. Chen Correction of perfusate concentration for sample removal J. Pharm. Sci. 71 1982 820 821
28. H.O. Ho, L.C. Chen, H.M. Lin, and M.T. Sheu Penetration enhancement by menthol combined with a solubilization effect in a mixed solvent system J. Control. Release 51 1998 301 311
29. A.C. Williams, and B.W. Barry Terpenes and the lipid-protein partitioning theory of skin penetration enhancement Pharm. Res. 8 1991 17 24
30. Y.S.R. Krishnaiah, V. Satyanarayana, and P. Bhaskar Influence of nerodilol on the bioavailability of nicardipine hydrochloride from membrane-moderated transdermal therapeutic systems in human volunteers Int. J. Pharm. 247 2002 91 102
31. Y.S.R. Krishnaiah, V. Satyanarayana, and P. Bhaskar Influence of menthol and pressure sensitive adhesives on the in vivo performance of membrane-moderated transdermal therapeutic system of nicardipine hydrochloride in human volunteers Eur. J. Pharm. Biopharm. 55 2003 329 337
32. M.C. Musolf Pressure-sensitive adhesives: science and engineering Y.W. Chien Transdermal Controlled Systemic Medications 1987 Marcel Dekker New York 93 112
33. I. Diez, H. Colom, J. Moreno, R. Obach, C. Peraire, and J. Domenech A comparative in vitro study of transdermal absorption of a series of calcium channel antagonists J. Pharm. Sci. 80 1991 931 934
34. J.N. Hunt, and W.R. Spurrell The pattern of emptying of the human stomach J. Physiol. 113 1951 157 168
35. J.N. Hunt Gastric emptying and secretion in man Physiol. Rev. 39 1959 491 533
36. S.K. Jain, S.P. Vyas, and V.K. Dixit Effective and controlled transdermal delivery of ephedrine J. Control. Release 12 1990 257 263